These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17532633)

  • 1. Pyrazolone methylamino piperidine derivatives as novel CCR3 antagonists.
    Pégurier C; Collart P; Danhaive P; Defays S; Gillard M; Gilson F; Kogej T; Pasau P; Van Houtvin N; Van Thuyne M; van Keulen B
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4228-31. PubMed ID: 17532633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,4-Disubstituted piperidines as selective CC chemokine receptor 3 (CCR3) antagonists: synthesis and selectivity.
    Watson PS; Jiang B; Harrison K; Asakawa N; Welch PK; Covington M; Stowell NC; Wadman EA; Davies P; Solomon KA; Newton RC; Trainor GL; Friedman SM; Decicco CP; Ko SS
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5695-9. PubMed ID: 16931001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthesis of substituted bipiperidine amide compounds as CCR3 antagonists.
    Ting PC; Lee JF; Wu J; Umland SP; Aslanian R; Cao J; Dong Y; Garlisi CG; Gilbert EJ; Huang Y; Jakway J; Kelly J; Liu Z; McCombie S; Shah H; Tian F; Wan Y; Shih NY
    Bioorg Med Chem Lett; 2005 Mar; 15(5):1375-8. PubMed ID: 15713390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists.
    Batt DG; Houghton GC; Roderick J; Santella JB; Wacker DA; Welch PK; Orlovsky YI; Wadman EA; Trzaskos JM; Davies P; Decicco CP; Carter PH
    Bioorg Med Chem Lett; 2005 Feb; 15(3):787-91. PubMed ID: 15664858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthesis of substituted bipiperidine amide compounds as CCR3 ligands: antagonists versus agonists.
    Ting PC; Umland SP; Aslanian R; Cao J; Garlisi CG; Huang Y; Jakway J; Liu Z; Shah H; Tian F; Wan Y; Shih NY
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3020-3. PubMed ID: 15908209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CC chemokine receptor-3 (CCR3) antagonists: improving the selectivity of DPC168 by reducing central ring lipophilicity.
    Pruitt JR; Batt DG; Wacker DA; Bostrom LL; Booker SK; McLaughlin E; Houghton GC; Varnes JG; Christ DD; Covington M; Das AM; Davies P; Graden D; Kariv I; Orlovsky Y; Stowell NC; Vaddi KG; Wadman EA; Welch PK; Yeleswaram S; Solomon KA; Newton RC; Decicco CP; Carter PH; Ko SS
    Bioorg Med Chem Lett; 2007 Jun; 17(11):2992-7. PubMed ID: 17418570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency.
    De Lucca GV; Kim UT; Vargo BJ; Duncia JV; Santella JB; Gardner DS; Zheng C; Liauw A; Wang Z; Emmett G; Wacker DA; Welch PK; Covington M; Stowell NC; Wadman EA; Das AM; Davies P; Yeleswaram S; Graden DM; Solomon KA; Newton RC; Trainor GL; Decicco CP; Ko SS
    J Med Chem; 2005 Mar; 48(6):2194-211. PubMed ID: 15771462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for the enantioselective synthesis of trans-2,4-disubstituted piperidines: application to the CCR3 antagonist IS811.
    Kauffman GS; Watson PS; Nugent WA
    J Org Chem; 2006 Nov; 71(23):8975-7. PubMed ID: 17081035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel spiro-piperidine derivatives as highly potent and selective melanin-concentrating hormone 1 receptor antagonists.
    Suzuki T; Moriya M; Sakamoto T; Suga T; Kishino H; Takahashi H; Ishikawa M; Nagai K; Imai Y; Sekino E; Ito M; Iwaasa H; Ishihara A; Tokita S; Kanatani A; Sato N; Fukami T
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3072-7. PubMed ID: 19403308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and structure-activity relationship of N-(ureidoalkyl)-benzyl-piperidines as potent small molecule CC chemokine receptor-3 (CCR3) antagonists.
    De Lucca GV; Kim UT; Johnson C; Vargo BJ; Welch PK; Covington M; Davies P; Solomon KA; Newton RC; Trainor GL; Decicco CP; Ko SS
    J Med Chem; 2002 Aug; 45(17):3794-804. PubMed ID: 12166951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel CCR3 antagonists.
    Gong L; Hogg JH; Collier J; Wilhelm RS; Soderberg C
    Bioorg Med Chem Lett; 2003 Oct; 13(20):3597-600. PubMed ID: 14505678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation, and metabolic stability of acrylamide derivatives as novel CCR3 antagonists.
    Sato I; Morihira K; Inami H; Kubota H; Morokata T; Suzuki K; Ohno K; Iura Y; Nitta A; Imaoka T; Takahashi T; Takeuchi M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2009 Aug; 17(16):5989-6002. PubMed ID: 19620010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of N-propylurea 3-benzylpiperidines as selective CC chemokine receptor-3 (CCR3) antagonists.
    Varnes JG; Gardner DS; Santella JB; Duncia JV; Estrella M; Watson PS; Clark CM; Ko SS; Welch P; Covington M; Stowell N; Wadman E; Davies P; Solomon K; Newton RC; Trainor GL; Decicco CP; Wacker DA
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1645-9. PubMed ID: 15026042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule antagonists of the CCR2b receptor. Part 2: Discovery process and initial structure-activity relationships of diamine derivatives.
    Moree WJ; Kataoka K; Ramirez-Weinhouse MM; Shiota T; Imai M; Sudo M; Tsutsumi T; Endo N; Muroga Y; Hada T; Tanaka H; Morita T; Greene J; Barnum D; Saunders J; Kato Y; Myers PL; Tarby CM
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5413-6. PubMed ID: 15454236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and SAR of biaryl piperidine MCH1 receptor antagonists through solid-phase encoded combinatorial synthesis.
    Guo T; Shao Y; Qian G; Rokosz LL; Stauffer TM; Hunter RC; Babu SD; Gu H; Hobbs DW
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3696-700. PubMed ID: 15978811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivatives.
    Lu SF; Chen B; Davey D; Dunning L; Jaroch S; May K; Onuffer J; Phillips G; Subramanyam B; Tseng JL; Wei RG; Wei M; Ye B
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1883-7. PubMed ID: 17314043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of phenyl piperidine derivatives as CCR2 antagonists.
    Xia M; Hou C; Pollack S; Brackley J; DeMong D; Pan M; Singer M; Matheis M; Olini G; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5964-8. PubMed ID: 17869105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure-activity relationships of N-{1-[(6-fluoro-2-naphthyl)methyl]piperidin-4-yl}benzamide derivatives as novel CCR3 antagonists.
    Sato I; Morihira K; Inami H; Kubota H; Morokata T; Suzuki K; Hamada N; Iura Y; Nitta A; Imaoka T; Takahashi T; Takeuchi M; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2008 Jan; 16(1):144-56. PubMed ID: 17951061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrrolidinohydroquinazolines--a novel class of CCR3 modulators.
    Anderskewitz R; Bauer R; Bodenbach G; Gester D; Gramlich B; Morschhäuser G; Birke FW
    Bioorg Med Chem Lett; 2005 Feb; 15(3):669-73. PubMed ID: 15664834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8).
    Ghosh S; Elder A; Guo J; Mani U; Patane M; Carson K; Ye Q; Bennett R; Chi S; Jenkins T; Guan B; Kolbeck R; Smith S; Zhang C; LaRosa G; Jaffee B; Yang H; Eddy P; Lu C; Uttamsingh V; Horlick R; Harriman G; Flynn D
    J Med Chem; 2006 May; 49(9):2669-72. PubMed ID: 16640325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.